Machine Learning Model to Predict Postmastectomy Breast Reconstruction Complications
JAMA Network Open · 2026
DOI: 10.1001/jamanetworkopen.2026.7232 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JAMA Network Open, 2026. Verfasst von Mohammed S Shaheen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Section of Plastic Surgery, Department of Surgery, University of Michigan Medical School, Ann Arbor. Hauptthemen laut MEDLINE: Machine Learning, Predictive Learning Models, Mammaplasty, Mastectomy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance Postmastectomy breast reconstruction (PMBR) improves patients’ quality of life, but patients often lack reliable, individualized information about complication risk. Machine learning (ML) can analyze complex clinical data to generate personalized risk estimates, facilitating shared decision-making.
Objective
To develop and validate ML models trained on both structured data and manually abstracted variables from unstructured clinical notes to predict major complications after PMBR. Design, Setting, and Participants This prognostic study used retrospective data from female patients aged 18 years or older who underwent unilateral or bilateral therapeutic mastectomy with immediate or delayed implant-based or autologous reconstruction at 2 academic centers in the US from 2012 to 2022. Demographic, treatment, and surgical variables were extracted from electronic health records with a 1-year postoperative follow-up period. Extreme gradient boosting (XGBoost) and random forest models were trained on 80% of the cohort (329 individuals) and tested on 20% of the cohort (82 individuals). Patients with bilateral prophylactic mastectomy, distant metastases, mixed autologous and implant-based reconstruction, or less than 12 months of follow-up were excluded. Of more than 4000 eligible patients, a random sample of 411 underwent manual health record review for variable abstraction. Data were analyzed from September through November 2024. Exposures PMBR. Main Outcomes and Measures Outcomes of interest were major complications, defined as unplanned reoperations or rehospitalizations within 1 year of reconstruction. Model performance was evaluated using the area under the receiver operating characteristic curve (AUROC) and area under the precision-recall curve (AUPRC).
Results
The sample included 411 female patients (667 breasts) receiving implant-based (290 individuals [70.6%]) or autologous (121 individuals [29.4%]) PMBR, with a median (IQR) age of 51.3 (44.0-58.3) years. The overall major complication rate was 25.8% (106 individuals). The XGBoost model outperformed the random forest model, achieving an AUROC of 0.83 (95% CI, 0.72-0.94) and an AUPRC of 0.62 (95% CI, 0.55-0.69; baseline: 0.26) on the test set, compared with 0.74 (95% CI, 0.66-0.82) and 0.56 (95% CI, 0.50-0.62), respectively, for the random forest model. Top predictors of major complications included smoking, adjuvant radiotherapy, body mass index, age, and diabetes. Model performance remained consistent across reconstructive modalities. Conclusions and Relevance In this prognostic study of PMBR outcomes, an internally validated ML model trained on both structured and unstructured clinical data was used to predict 1-year major complications. Such models support personalized risk assessment, inform decision-making, and provide a foundation for future externally validated and prospectively tested decision-support tools.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Section of Plastic Surgery, Department of Surgery, University of Michigan Medical School, Ann Arbor.
- Division of Plastic and Reconstructive Surgery, Stanford University School of Medicine, Stanford, California.
- Department of Plastic and Reconstructive Surgery, MedStar Georgetown University Hospital, Washington, District of Columbia.
- Division of Rheumatology, Allergy and Immunology, Department of Internal Medicine, New Taipei Municipal TuCheng Hospital, New Taipei City, Taiwan.
- Division of Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
- Center for Artificial Intelligence in Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Zitieren
APA
Shaheen, M. S., McManus, B. T., Cullen, C. M., Chen, J. S., Momeni, A., Kuo, C. F., Tsai, P. H., & Chung, K. C. (2026). Machine Learning Model to Predict Postmastectomy Breast Reconstruction Complications. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2026.7232
Vancouver
Shaheen MS, McManus BT, Cullen CM, Chen JS, Momeni A, Kuo CF, et al. Machine Learning Model to Predict Postmastectomy Breast Reconstruction Complications. JAMA Network Open. 2026. doi:10.1001/jamanetworkopen.2026.7232
BibTeX
@article{Shaheen2026,
author = {Shaheen, Mohammed S and McManus, Brennen T and Cullen, Clara M and Chen, Jung-Sheng and Momeni, Arash and Kuo, Chang-Fu and Tsai, Ping-Han and Chung, Kevin C},
title = {Machine Learning Model to Predict Postmastectomy Breast Reconstruction Complications},
journal = {JAMA Network Open},
year = {2026},
doi = {10.1001/jamanetworkopen.2026.7232}
}
EUVIMED